Immediate Impact

1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
2024 Standout
2 intermediate papers

Works of Anna Turco being referenced

Effect of treatment with acarbose and insulin in patients with non‐insulin‐dependent diabetes mellitus associated with non‐alcoholic liver cirrhosis
2001

Author Peers

Author Last Decade Papers Cites
Anna Turco 113 143 79 102 19 282
Hitoshi Miyajima 103 231 146 36 25 330
Takahiro Nishihara 46 173 49 51 24 244
J.M. Coenegracht 79 124 57 43 21 290
Sheena Thomas 59 196 107 41 17 289
Jun Hua Chong 56 135 53 56 20 244
Bryan Raybuck 116 250 39 17 22 322
Joseph L. Fredi 36 166 102 24 27 269
Malek Al‐Hawwas 53 151 149 129 18 311
Terrance Chua 65 207 70 57 26 310
S Toniolo 85 202 54 57 15 270

All Works

Loading papers...

Rankless by CCL
2026